Jaguar Health, Inc.
NASDAQJaguar Health heads into its May 21 earnings report with the lending market telling a more alarming story than the short interest numbers alone suggest. The borrow market has tightened dramatically over the past month. Cost to borrow has surged to 234% annualised — more than eleven times the ~21% level recorded at end-April. That move reflects acute scarcity: availability has been…
JAGX short interest plummets 25.3% in a week to 2.9% of float, lowest level in months, as cost to borrow surges 234% — signaling acute scarcity despite falling short positions.
Jaguar Health heads into its May 21 earnings report with the lending market telling a more alarming story than the short interest numbers alone suggest. The borrow market has tightened dramatically over the past month.…
JAGX cost to borrow has more than doubled in a week. That's the headline in Jaguar Health's lending market right now. Cost to borrow stood at 52% as of May 7. A week earlier it was 18.7%. That's a 178% jump in seven…
Snapshot as of 22 Jun 2026
JAGX has entered an extraordinary stretch of dislocation — the stock is down 64% on the week and nearly 79% over the past month, trading at $3.01 after a brutal post-reverse-split unwind that has compressed the market…
Jaguar Health is flashing a rare three-way convergence. The borrow market is almost completely locked. Options traders are overwhelmingly bullish. Short interest sits at a meaningful 12.3% of float. Each signal points…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for JAGX — free to start on ORTEX.
Sign up for free →Open JAGX on ORTEX